How about GENE trading 6 times the volume of ROSG today, even though at 1.5 million shares ROSG is having a big volume day? Clearly there are more people paying attention to GENE.
Someone on this board mentioned GENE as a good companion stock for ROSG (same industry, roughly same market cap, development stage, etc.). Well today GENE is up 30% on no news while ROSG continues to linger around the 52 week lows. Both are volatile, but ROSG is just 27% of the 52 week high while GENE is at 35% of the 52 week high. More telling, GENE was at a high of 60 ten years ago while ROSG was at 400 (split adjusted) 10 years ago. It would seem that if you are investing in microcaps, GENE should be the higher weighted position in your portfolio.
If he were really greedy, he'd be buying shares with his own cash on the open market. If he just used 10% of his salary this year to buy shares, he'd own 5 times as many shares as I do and have paid substantially less in total than I have.
...and of course at a luxury hotel. I imagine he shows a price chart and says "if you buy it here, you'll get it at a better price than everyone else who bought in the last 8 years. What's not to like?"
I bet they are underwater already. They don't understand that bad news (company specific, industry, or geopolitical) is a reason to sell, and good news is like a ripe banana (sell while you can; tomorrow it is mush.)
6% stake? Nice, but net of company cash, that's only about $1 million of equity investment. That's a weak sales day for many companies.
Share price went down yesterday because gross margins are negative. The more you sell, the more money you lose. Think I'm kidding? Look at past income statements. OK, so if they can generate enough tests, the margins may turn positive, but who knows how long that will take.
Lots of near term 30 call options sold/bought over the past couple of days (very few puts). Typically an indication of positive expectations for share price. So this big decline on an good report and shares already down 40+ % is a surprise.
Revenue increase is only important for cult stocks like TSLA and FB. Let's face it, if the big boys want it to go down, they'll find some excuse to drive down the price. That said, AH is a terrible measure of overall market sentiment. Check out DDD. They missed all their numbers and stock was down 5% in PM and closed the day up 10%.
Last secondary sold at 2.40, I think. Of course they got some long term options as part of the deal. I bet most just sold the stock as fast as they could and treated the whole deal like a long shot option. Minimal or no cash tied up and who knows, maybe dumb luck gives them a windfall.
It seems to me that too much trading is based on technicals and as long everyone trades on the generally accepted technicals, the technical trend becomes a bigger price driver than any news. Now if someone figures out how to track the technicals as a group and anticipate their movement, it'll be easy money. In fact, I think that is what some of the bigger investment houses or hedge funds are doing.
I noticed. It could be shorts hedging their positions. Obviously expectation is for a big move up or down based on earnings, or perhaps the mythical buy-out.
Well, there must be a fair number of hedging shorts. Look at the volume on the Nov 30 calls.
It would be helpful to know what sort of business development he championed. If the board seeks a new CEO with a similar approach, the trend down continues. If they are looking for someone who can radically shift the strategy, this might be the bottom. I saw this in a drug company. Share price was sliding down every day even though product had lots of potential. CEO quit/fired and stock jumped 30%.